EQUITY PURCHASE AGREEMENTEquity Purchase Agreement • May 14th, 2021 • Axim Biotechnologies, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMay 14th, 2021 Company Industry JurisdictionThis equity purchase agreement is entered into as of May 14, 2021 (this “Agreement”), by and between AXIM Biotechnologies, Inc., a Nevada corporation (the “Company”), and Cross & Company, a Nevada corporation (the “Investor”).